Laden...
Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients. Here's what to know. ⤵️
BREAKING: FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent
| Do you know someone who would like to receive The Advocate newsletter? Share it with them! |
| Click to email a link to your friends |
| Keep up with the latest LGBTQ+ news -- from politics to entertainment to opinions from queer voices. |
The Advocate is part of equalpride, a proudly LGBTQ-owned and operated media company that serves as a leading voice on equality with LGBTQ, women and people of color.
Follow usCopyright © 2024 equalpride. All rights reserved.
PO Box 241579, Los Angeles, CA 90024
Privacy policy Unsubscribe Terms of useLaden...
Laden...
